• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of CVM advisory committee member positions vacant at the end of the month

Dictionary: Access to state-of-the-art, scientific expert advice to support agency decision making processes is imperative to the FDA advisory committee process. Having the fewest vacancies on our committees allows the agency to have ready access to those experts and supports the ability of FDA to meet its public health mission. For more information about FDA advisory committees, please visit http://www.fda.gov/AdvisoryCommittees/default.htm

Information is current as of September 30, 2013.

Fiscal Year - 2010

Skip graphic and jump to text data

TimeTargetPercent Vacant Positions
Oct 20091014
Nov 20091014
Dec 200910TBD
Jan 201010TBD
Feb 20101014
Mar 20101014
Apr 20101014
May 20101014
Jun 20101014
Jul 20101014
Aug 20101014
Sep 20101014

Footnotes

  • CVM's Advisory Committee was terminated on September 30, 2013.

Number of CVM advisory committee member positions vacant at the end of the month

Fiscal Year - 2010
Skip graphic and jump to text data.

TimeTargetVacant Positions
Oct 2009N/A2
Nov 2009N/A2
Dec 2009N/ATBD
Jan 2010N/ATBD
Feb 2010N/A2
Mar 2010N/A2
Apr 2010N/A2
May 2010N/A2
Jun 2010N/A2
Jul 2010N/A2
Aug 2010N/A2
Sep 2010N/A2

Total number of CVM advisory committee member positions at the end of the month

Fiscal Year - 2010
Skip graphic and jump to text data.

TimeTargetPositions
Oct 2009N/A14
Nov 2009N/A14
Dec 2009N/ATBD
Jan 2010N/ATBD
Feb 2010N/A14
Mar 2010N/A14
Apr 2010N/A14
May 2010N/A14
Jun 2010N/A14
Jul 2010N/A14
Aug 2010N/A14
Sep 2010N/A14

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.